Abstract
We review recent progress in the discovery and development of small molecule inhibitors against chronic hepatitis B and C infections by listing of the current therapeutic agents and in-depth discussing chemical synthesis and biological results of the recent inhibitor candidates. At present six antiviral drugs have been formally licensed for treatment of chronic HBV infection namely interferon alfa, pegylated interferon alfa-2a and antiviral agents; lamivudine, entecavir, telbivudine and adefovir. Unfortunately, treatment is associated with several side effects and the response rate has been unsatisfactory. β-LPA was recently discovered as a new drug candidate that inhibits viral replication and still in phases II of clinical development. There is an urgent need for the development of novel classes of anti-HBV agents with new molecular structures and optimal pharmacological profiles for the chemotherapy of HBV infection. Although HCV infection can be cured in up to 40% of patients, current treatment is not ideal and is associated with a wide spectrum of side effects and complications. Treatment for HCV has gone through several milestones with the introduction of interferon (IFN) in the early 1990s, the addition of ribavirin in the late 1990s, the pegylation of IFN, and now to the new oral therapies such as BILN 2061, VX-950, JTK-109 and many peptides inhibitors that inhibit viral replication or the translation of viral RNA are in various phases of clinical development. In general, the development of drug-like inhibitors has proven to be a challenging task.
Keywords: Chronic Hepatitis Infections, inhibitors, interferon alfa, antiviral agents, chemotherapy
Current Organic Chemistry
Title: Current Chemical Approaches Directed Toward New and Effective Therapeutic Agents Against Chronic Hepatitis Infections
Volume: 13 Issue: 4
Author(s): Hammed H. A. M. Hassan
Affiliation:
Keywords: Chronic Hepatitis Infections, inhibitors, interferon alfa, antiviral agents, chemotherapy
Abstract: We review recent progress in the discovery and development of small molecule inhibitors against chronic hepatitis B and C infections by listing of the current therapeutic agents and in-depth discussing chemical synthesis and biological results of the recent inhibitor candidates. At present six antiviral drugs have been formally licensed for treatment of chronic HBV infection namely interferon alfa, pegylated interferon alfa-2a and antiviral agents; lamivudine, entecavir, telbivudine and adefovir. Unfortunately, treatment is associated with several side effects and the response rate has been unsatisfactory. β-LPA was recently discovered as a new drug candidate that inhibits viral replication and still in phases II of clinical development. There is an urgent need for the development of novel classes of anti-HBV agents with new molecular structures and optimal pharmacological profiles for the chemotherapy of HBV infection. Although HCV infection can be cured in up to 40% of patients, current treatment is not ideal and is associated with a wide spectrum of side effects and complications. Treatment for HCV has gone through several milestones with the introduction of interferon (IFN) in the early 1990s, the addition of ribavirin in the late 1990s, the pegylation of IFN, and now to the new oral therapies such as BILN 2061, VX-950, JTK-109 and many peptides inhibitors that inhibit viral replication or the translation of viral RNA are in various phases of clinical development. In general, the development of drug-like inhibitors has proven to be a challenging task.
Export Options
About this article
Cite this article as:
Hassan H. A. M. Hammed, Current Chemical Approaches Directed Toward New and Effective Therapeutic Agents Against Chronic Hepatitis Infections, Current Organic Chemistry 2009; 13 (4) . https://dx.doi.org/10.2174/138527209787582277
DOI https://dx.doi.org/10.2174/138527209787582277 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
Call for Papers in Thematic Issues
Advances of Heterocyclic Chemistry with Pesticide Activity
Global food safety and security will continue to be a global concern for the next 50 years and beyond. Plant diseases have had a significant impact on food safety and security throughout the entire food chain, from primary production to consumption. While conventional chemical pesticides have been traditionally used for ...read more
Calculation design of covalent/metal organic framework based catalysts
This research area combines theoretical computation and screening with machine learning for the design of covalent/metal organic framework-based catalysts, bridging the disciplines of organic chemistry, physical chemistry, computational chemistry, materials science, and machine learning. It covers several critical aspects: designing and synthesizing organic catalysts for improved performance, applying computational methods ...read more
Carbohydrates conversion in biofuels and bioproducts
Biomass pretreatment, hydrolysis, and saccharification of carbohydrates, and sugars bioconversion in biofuels and bioproducts within a biorefinery framework. Carbohydrates derived from woody biomass, agricultural wastes, algae, sewage sludge, or any other lignocellulosic feedstock are included in this issue. Simulation, techno-economic analysis, and life cycle analysis of a biorefinery process are ...read more
Catalytic C-H bond activation as a tool for functionalization of heterocycles
The major topic is the functionalization of heterocycles through catalyzed C-H bond activation. The strategies based on C-H activation not only provide straightforward formation of C-C or C-X bonds but, more importantly, allow for the avoidance of pre-functionalization of one or two of the cross-coupling partners. The beneficial impact of ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Cholinergic Potential, the Vagus Nerve and Challenges in Treatment of Traumatic Brain Injury
Current Pharmaceutical Design Polymeric Nanomedicines as a Promising Vehicle for Solid Tumor Therapy and Targeting
Current Molecular Medicine Application of Bone Marrow Stem Cell Based Therapy in Bone Loss Diseases
Current Pharmaceutical Design An Overview of Interleukin-1 Receptor Antagonist, Anakinra, in the Treatment of Cutaneous Diseases
Current Clinical Pharmacology Candidiasis and HIV-Protease Inhibitors: The Expected and the Unexpected
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Complement System in SLE as a Target for Antibodies
Current Rheumatology Reviews Probing into Therapeutic Anti-cancer Potential of Apigenin: Recent Trends and Future Directions
Recent Patents on Inflammation & Allergy Drug Discovery Interaction Between Arsenic Trioxide and Human Primary Cells: Emphasis on Human Cells of Myeloid Origin
Inflammation & Allergy - Drug Targets (Discontinued) PET Radioligands for In Vivo Visualization of Neuroinflammation
Current Pharmaceutical Design Adverse Dermatological Reactions in Rheumatoid Arthritis Patients Treated with Etanercept, an Anti-TNFα Drug
Current Drug Safety Development of Electrochromic Devices
Recent Patents on Nanotechnology The Chick Embryo Chorioallantoic Membrane Model: A Research Approach for <i>Ex Vivo</i> and <i>In Vivo</i> Experiments
Current Medicinal Chemistry Editorial [Hot Topic: Essential Fatty Acids (Guest Editor: Undurti N. Das)]
Current Pharmaceutical Biotechnology The Influence of Sex Hormones on Pulmonary Vascular Reactivity: Possible Vasodilator Therapies for the Treatment of Pulmonary Hypertension
Current Vascular Pharmacology Biphasic Vesicles for Topical Delivery of Interferon Alpha in Human Volunteers and Treatment of Patients with Human Papillomavirus Infections
Current Drug Delivery Proteomic Studies on Plant-Pathogen Interaction in Compatible and Incompatible Systems
Current Proteomics How Should Serum Uric Acid Concentrations be Interpreted in Patients with Hypertension?
Current Hypertension Reviews The Emerging Role of TRP Channels in Mechanisms of Temperature and Pain Sensation
Current Neuropharmacology Drug Eluting Coronary Artery Stents
Current Drug Delivery Gene Therapy for Chronic Granulomatous Disease: Current Status and Future Perspectives
Current Gene Therapy